Infinity Pharmaceuticals Inc. (INFI) Upgraded to "Neutral" by Wedbush
Wedbush currently has $1.50 price target on the stock, down from their prior price target of $3.00. Infinity Pharmaceuticals opened at 1.36 on Tuesday.
from Biotech News
Wedbush currently has $1.50 price target on the stock, down from their prior price target of $3.00. Infinity Pharmaceuticals opened at 1.36 on Tuesday.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments